Detailed ExplanationMidwife Licensure Exam · Midwifery Pharmacology & Newborn ProceduresReal content

Midwife Licensure Exam Midwifery Pharmacology & Newborn Procedures — Midwifery Pharmacology — The Limited FormularyDetailed Explanation

Summary Concepts Notes Revision Deep Dive Slides Flashcards Mistakes Cheat Mnemonics Templates

Detailed explanations for Midwife Licensure Exam Midwifery Pharmacology & Newborn Procedures — Midwifery Pharmacology — The Limited Formulary. This page treats you like a serious reviewer: we unpack the concepts thoroughly, show worked examples of how Professional Regulation Commission (PRC) — Board of Midwifery frames Midwifery Pharmacology — The Limited Formulary questions, and explain the underlying reasoning that gets you to the right answer every time.

Exam context

The Midwife Licensure Examination is conducted by Professional Regulation Commission (PRC) — Board of Midwifery and is scheduled for April and November 2026 (expected). The Midwifery Pharmacology & Newborn Procedures subtest is marked as "Core" in the official pattern, and Midwifery Pharmacology — The Limited Formulary appears in position 1st of 4 in the Midwife Licensure Exam Midwifery Pharmacology & Newborn Procedures review rotation. Passing mark: 75% weighted average. Recent Midwife Licensure Exam 2026 papers have drawn roughly a meaningful share of questions from this subject.

Midwifery Pharmacology — The Limited Formulary - Detailed Explanation

Under Republic Act No. 7392 (The Philippine Midwifery Act of 1992), a registered midwife is authorized to provide normal prenatal, intranatal, and postnatal care, and to render first-aid and emergency measures in the absence of a physician. This authority comes with a clearly defined boundary: the midwife works from a SHORT, SPECIFIC list of drugs that are safe, life-saving, and appropriate for primary maternal-newborn care in community settings such as the Barangay Health Station (BHS), Rural Health Unit (RHU), and lying-in clinic. The most important exam principle to master is this: the midwife administers a NARROW SET of essential drugs — primarily oxytocics, micronutrients, immunizing agents, and one emergency anticonvulsant loading dose — and REFERS everything else to a physician or higher-level facility. Mastering exactly WHAT IS inside and WHAT IS outside the formulary is both high-yield for the MLE and critical for patient safety. This chapter covers every drug category in the midwife's limited formulary, with the correct doses, routes, timing, indications, contraindications, and the key boundaries a midwife must never cross.

Concepts

The Concept of a Limited Formulary Under RA 7392

A formulary is simply a list of approved medicines that a health worker is authorized to use. Under RA 7392, the midwife's formulary is DELIBERATELY LIMITED because her scope of practice is defined as NORMAL care — supporting healthy births, preventing specific deficiencies and infections, and providing life-saving first-aid measures before referral. She is NOT a prescriber of therapeutic drugs for disease treatment. Think of it this way: A midwife is like a skilled safety officer at a construction site. She has a first-aid kit with specific tools — bandages, antiseptic, a splint — but she does not perform surgery. She stabilizes the patient and calls for the surgeon. Similarly, the midwife has her specific drugs for normal birth, and when complications arise, she stabilizes with what she has and REFERS. The practical rule for the MLE: If a drug SUPPORTS a NORMAL birth process OR PREVENTS a defined deficiency/infection, it is likely INSIDE the formulary. If a drug TREATS a disease, a complication, or a pathological condition, it is likely OUTSIDE the formulary and the correct answer is REFER.

Examples

Oxytocin use for labor INDUCTION or AUGMENTATION is a physician act. Using oxytocin before delivery of the baby can cause uterine hyperstimulation, uterine rupture, and fetal death. The midwife's use of oxytocin is confined EXCLUSIVELY to the THIRD STAGE of labor and PPH management. This is a critically tested boundary.

Scenario

A midwife at a BHS is attending to a woman in active labor whose cervical dilation is progressing slowly. The barangay captain suggests giving an injection to 'speed up' the labor. What should the midwife do?

Solution

The midwife should NOT give oxytocin or any uterotonic to speed up (augment) labor. She should assess the woman, monitor maternal and fetal well-being, and if there is true labor dystocia or non-reassuring fetal status, arrange REFERRAL to an appropriate facility with physician care.

High-dose Vitamin A (such as the 200,000 IU capsule given postpartum) is CONTRAINDICATED during pregnancy because of teratogenicity. Postpartum Vitamin A (200,000 IU once) is given according to current DOH policy AFTER delivery, not during pregnancy. This is a common exam trap.

Scenario

A midwife is conducting an antenatal visit at the RHU. The pregnant woman asks if she can take the Vitamin A capsule her neighbor gave her since she heard it is good for the baby's eyes. What should the midwife counsel?

Solution

The midwife should advise the pregnant woman NOT to take high-dose Vitamin A supplements during pregnancy. She should explain that high-dose Vitamin A is TERATOGENIC (can cause birth defects) during pregnancy. Iron and folic acid supplementation is what is routinely given during pregnancy.

Applications

Screening which drugs are within the midwife's scope before administering
Counseling pregnant women and mothers about what to expect during care at BHS/RHU
Correct referral decisions when a condition requires drugs outside the formulary
Documentation and recording of all administered drugs in FHSIS registers
Community health education on the role of the midwife versus the physician

Misconceptions

MISCONCEPTION: The midwife can give any drug in an emergency. TRUTH: Even in emergencies, the midwife gives ONLY the specific first-aid/stabilizing doses within her formulary (e.g., MgSO4 loading dose) and REFERS immediately.
MISCONCEPTION: A midwife can give antibiotics for wound infections at the BHS. TRUTH: Antibiotic therapy for infections requires physician prescription; the midwife refers.
MISCONCEPTION: Oxytocin is oxytocin — the midwife can use it whenever needed. TRUTH: The midwife's oxytocin use is STRICTLY limited to the 3rd stage of labor and PPH — NEVER before delivery of the baby.
MISCONCEPTION: Since Vitamin A is a vitamin (not a drug), it is always safe in pregnancy. TRUTH: HIGH-DOSE Vitamin A is teratogenic and is CONTRAINDICATED during pregnancy.

Related Concepts

AMTSL (Active Management of the Third Stage of Labor)
BEmONC (Basic Emergency Obstetric and Newborn Care) competencies
EINC/Unang Yakap essential newborn care
RA 7392 Scope of Midwifery Practice
DOH MNCHN Program drug supply at BHS level

Common Exam Questions

Example

A woman develops fever and purulent vaginal discharge on her 3rd postpartum day. The midwife should: A) Give amoxicillin B) Give metronidazole C) Refer to a physician D) Give erythromycin. ANSWER: C — antibiotic treatment of postpartum infection is a physician act; the midwife REFERS.

Approach

Read the scenario carefully — is the drug being asked about SUPPORTING NORMAL BIRTH or TREATING A DISEASE/COMPLICATION? If treating, the answer is almost always REFER.

Question Type

Scope of Practice

Example

Which of the following is within the scope of a midwife? A) Augmenting labor with oxytocin drip B) Giving oxytocin 10 IU IM after delivery of the baby C) Administering magnesium sulfate maintenance dose D) Prescribing antihypertensives. ANSWER: B

Approach

Be alert for oxytocin before delivery of the baby — this is ALWAYS wrong for the midwife regardless of how the question frames it.

Question Type

Drug Boundary Identification

Key Points To Remember

RA 7392 defines the midwife's scope as NORMAL care — the formulary reflects this
The midwife is NOT a prescriber; she administers from a defined, limited list
INSIDE the formulary: oxytocics (3rd stage/PPH only), Vitamin K, eye prophylaxis, iron/folic acid, Vitamin A (postpartum), Td vaccine, FP methods, MgSO4 loading dose
OUTSIDE the formulary: antibiotics for treatment, oxytocin for induction/augmentation, antihypertensives, insulin, anesthetics, narcotics, anticoagulants
The safest exam heuristic: drug treats a disease = REFER; drug supports normal birth/prevents deficiency = midwife may give
Setting matters: drugs are given at BHS, RHU, or lying-in clinic — community primary-care level

Oxytocics — The Core of AMTSL and PPH Response

Postpartum Hemorrhage (PPH) is the NUMBER ONE direct cause of maternal death in the Philippines. Oxytocics are drugs that cause the uterus to contract — they are the most important drugs in the midwife's formulary because they PREVENT and TREAT the leading cause of maternal death. There are three oxytocics the midwife must know in detail: OXYTOCIN, ERGOMETRINE/METHYLERGOMETRINE, and MISOPROSTOL. --- OXYTOCIN (AMTSL Drug of Choice) --- Oxytocin 10 IU IM given within ONE MINUTE of delivery of the baby (after confirming no second twin) is the cornerstone of AMTSL — Active Management of the Third Stage of Labor. This is the single most tested drug-dose-timing combination in the MLE. AMTSL has THREE components: 1. Give OXYTOCIN 10 IU IM within 1 minute of birth 2. CONTROLLED CORD TRACTION with counter-traction during a contraction 3. UTERINE MASSAGE after delivery of the placenta, then every 15 minutes for 2 hours Oxytocin is PREFERRED over ergometrine for routine AMTSL because: - It does NOT raise blood pressure (safe even when BP status is unknown or elevated) - Fewer side effects - Works quickly (within 1–3 minutes IM) For PPH treatment, the midwife's priority actions (memorize this order): 1. CALL FOR HELP / ARRANGE REFERRAL 2. MASSAGE THE UTERUS continuously 3. GIVE OXYTOCIN (repeat dose, or IV infusion: 20–40 IU in 1 L isotonic fluid if IV access and protocol allow) 4. EMPTY THE BLADDER (full bladder prevents uterine contraction) 5. CHECK FOR TEARS (perineal, vaginal, cervical) --- ERGOMETRINE / METHYLERGOMETRINE --- Ergometrine 0.2 mg IM is a SECOND-LINE uterotonic when oxytocin is unavailable or insufficient. ABSOLUTE CONTRAINDICATION: HYPERTENSION, PRE-ECLAMPSIA/ECLAMPSIA, and HEART DISEASE — because ergometrine causes VASOCONSTRICTION and RAISES BLOOD PRESSURE. Because a midwife in a community setting often cannot fully exclude hypertension, OXYTOCIN ALWAYS remains the first choice. --- MISOPROSTOL --- Misoprostol 600 mcg ORALLY immediately after birth is an accepted alternative for AMTSL where cold-chain storage is unavailable. For PPH treatment, 800 mcg may be used per DOH/WHO community protocols. Its main advantage is HEAT STABILITY — it does not require refrigeration, making it ideal for remote BHS settings.

Examples

The timing is CRITICAL — within 1 minute. The condition to check FIRST is: Is there a second twin? If confirmed only one baby, give oxytocin immediately. Do not wait for the placenta. Do not give before confirming single fetus — if there is a second twin and oxytocin is given, it will trap the second baby.

Scenario

A midwife just delivered the baby at a lying-in clinic. The baby cries immediately. She confirms there is only one baby. What is her FIRST action regarding AMTSL?

Solution

Within ONE MINUTE of birth, the midwife gives OXYTOCIN 10 IU IM (into the outer thigh/deltoid of the mother). This is the first and most critical component of AMTSL.

Atonic uterus is the most common cause of PPH. The midwife's role is to STABILIZE and REFER — not to manage PPH independently. She gives the uterotonic, massages, empties the bladder, and gets the woman to a higher level of care as fast as possible.

Scenario

After delivery of the placenta, a woman at the BHS starts bleeding heavily. The midwife estimates blood loss of over 500 mL. The uterus feels soft and not contracting (atonic PPH). What should the midwife do?

Solution

Immediate actions: (1) Call for help and arrange URGENT REFERRAL. (2) Perform continuous uterine massage. (3) Give oxytocin (if already given for AMTSL, can give additional dose or start IV infusion per protocol). (4) Empty the bladder with a catheter. (5) While doing the above, check for lacerations. Maintain IV access if available. Transport to referral facility immediately.

Oxytocin ideally requires cold-chain storage (2–8°C). In areas where cold chain cannot be maintained, misoprostol 600 mcg orally immediately after birth is the recommended alternative per DOH/WHO community protocols. The MLE tests this practical, real-world application.

Scenario

A midwife in a remote barangay without electricity or refrigeration is preparing for a home delivery. Which uterotonic should she stock and why?

Solution

MISOPROSTOL — because it is HEAT STABLE and does not require cold-chain storage, making it practical for remote community settings without refrigeration.

Applications

Routine AMTSL at every birth attended by a midwife (lying-in, BHS, home delivery)
Emergency stabilization of PPH before and during referral
Selection of appropriate uterotonic based on available resources (cold chain vs. no cold chain)
Contraindication screening before giving ergometrine (always check BP and history)
Documentation of uterotonic given, dose, time, and route in birth records

Misconceptions

MISCONCEPTION: Give ergometrine first because it is stronger. TRUTH: Oxytocin is the drug of CHOICE for AMTSL because it is safer (no BP effect). Ergometrine is SECOND LINE.
MISCONCEPTION: Oxytocin for PPH treatment means the midwife is managing a complication independently. TRUTH: The midwife gives oxytocin as a STABILIZING measure while arranging REFERRAL — she does not manage PPH alone.
MISCONCEPTION: Uterine massage is only needed if there is bleeding. TRUTH: Uterine massage is a ROUTINE part of AMTSL — after delivery of the placenta, every 15 minutes for 2 hours.
MISCONCEPTION: Misoprostol is only for hospitals. TRUTH: Misoprostol's heat stability makes it IDEAL for community/remote settings without cold chain.

Related Concepts

AMTSL (Active Management of the Third Stage of Labor)
BEmONC Signal Functions — administration of uterotonic
PPH definition (≥500 mL blood loss after vaginal birth)
Uterine atony as most common cause of PPH
Controlled cord traction technique (Brandt-Andrews maneuver)

Common Exam Questions

Example

The FIRST drug given in AMTSL is: A) Ergometrine 0.2 mg IM B) Misoprostol 600 mcg oral C) Oxytocin 10 IU IM D) Oxytocin 5 IU IV. ANSWER: C

Approach

Always remember: Oxytocin 10 IU IM within 1 MINUTE of birth. The number '10', the route 'IM', and the timing 'within 1 minute' are all testable. Do not confuse with IV doses used in PPH treatment.

Question Type

Drug-Dose-Timing (Most Tested)

Example

A woman with a BP of 160/110 has just delivered. Which uterotonic is CONTRAINDICATED? A) Oxytocin B) Misoprostol C) Ergometrine D) All of the above. ANSWER: C — Ergometrine is contraindicated in hypertension.

Approach

For any scenario involving a hypertensive or pre-eclamptic woman needing a uterotonic — the answer is NEVER ergometrine. Choose oxytocin.

Question Type

Contraindication Identification

Example

A midwife discovers PPH. Her FIRST priority action should be: A) Give oxytocin B) Massage uterus C) Call for help and arrange referral D) Empty the bladder. ANSWER: C

Approach

For PPH action questions, the sequence always starts with CALL FOR HELP/REFER, not with giving the drug. Patient safety and referral are always the first priority.

Question Type

Sequence/Priority

Key Points To Remember

AMTSL drug of choice: OXYTOCIN 10 IU IM within 1 MINUTE of birth (after ruling out 2nd twin)
AMTSL has 3 components: oxytocin, controlled cord traction, uterine massage
Oxytocin does NOT raise BP — safe even in unknown/elevated BP status
Ergometrine 0.2 mg IM is 2nd line — CONTRAINDICATED in hypertension/pre-eclampsia/eclampsia/heart disease
Misoprostol 600 mcg orally for AMTSL when cold chain is unavailable; 800 mcg for PPH treatment
Misoprostol's key advantage: HEAT STABLE — no cold chain needed
PPH priority: Refer/call help → Massage uterus → Give oxytocin → Empty bladder → Check for tears
OXYTOCIN FOR INDUCTION/AUGMENTATION = PHYSICIAN ACT — the midwife NEVER gives oxytocin before delivery of the baby
PPH = #1 direct maternal killer in the Philippines

Essential Newborn Drugs — Vitamin K and Eye Prophylaxis (EINC/Unang Yakap)

Under the EINC (Essential Intrapartum and Newborn Care) protocol — also called Unang Yakap — every newborn receives a standardized set of care interventions. Two of these involve drugs that the midwife must administer: VITAMIN K1 (to prevent bleeding) and EYE PROPHYLAXIS (to prevent eye infection). These are given as part of the DELAYED interventions in the Unang Yakap timeline — after the IMMEDIATE interventions of drying/thorough drying, skin-to-skin contact, and cord clamping/cutting. --- VITAMIN K1 (PHYTOMENADIONE) --- Why: Newborns are born with VERY LOW levels of Vitamin K because: 1. The placenta transfers Vitamin K poorly 2. The newborn's gut is sterile (no bacteria to produce Vitamin K) 3. Breast milk has low Vitamin K content This puts them at risk for VITAMIN K DEFICIENCY BLEEDING (VKDB), formerly called Hemorrhagic Disease of the Newborn (HDN) — a condition where the baby bleeds from multiple sites (umbilicus, circumcision, intracranial) due to lack of clotting factors. DOSE: - TERM infant (birth weight ≥ 1.5 kg): VITAMIN K1 1 mg IM - PRETERM/LOW BIRTH WEIGHT infant (< 1.5 kg): VITAMIN K1 0.5 mg IM - Single dose, given into the ANTEROLATERAL THIGH (vastus lateralis muscle) Timing: Within the FIRST HOUR of birth (as part of the post-birth care bundle) --- EYE PROPHYLAXIS (CREDÉ'S PROPHYLAXIS) --- Why: During vaginal birth, the newborn's eyes pass through the birth canal and may be exposed to maternal genital tract infections, particularly GONORRHEA (Neisseria gonorrhoeae) and CHLAMYDIA (Chlamydia trachomatis). Without prophylaxis, this can cause OPHTHALMIA NEONATORUM — severe conjunctivitis that can lead to blindness. DOH-PREFERRED AGENT: ERYTHROMYCIN 0.5% OPHTHALMIC OINTMENT - A thin ribbon applied into the lower conjunctival sac of EACH EYE - Alternative: Tetracycline 1% ophthalmic ointment - Historical agent: Silver nitrate (now largely replaced due to chemical conjunctivitis it causes) Timing: After initial eye-to-eye contact and skin-to-skin bonding (in the Unang Yakap sequence, NOT given in the immediate first minutes — bonding and initiation of breastfeeding happen first; eye ointment is among the slightly later post-birth interventions) CRITICAL RULE: Do NOT irrigate (wash) the eyes after applying the ointment — this removes the prophylactic agent.

Examples

The cutoff for dose selection is BIRTH WEIGHT 1.5 kg, not gestational age alone. Any infant (whether premature or small-for-gestational-age) with birth weight LESS THAN 1.5 kg gets 0.5 mg; those 1.5 kg and above get 1 mg. The injection site is always the anterolateral thigh in newborns — the vastus lateralis has adequate muscle mass and is away from major nerves and vessels.

Scenario

A midwife delivers a baby weighing 1.3 kg at 34 weeks gestation. What dose of Vitamin K1 should she give, and where?

Solution

VITAMIN K1 0.5 mg IM, injected into the ANTEROLATERAL THIGH (vastus lateralis muscle). The reduced dose (0.5 mg) is used because the birth weight is less than 1.5 kg (preterm/low birth weight infant).

Irrigating the eyes removes the antibiotic ointment and defeats the purpose of the prophylaxis. Temporary blurred vision after applying eye ointment is normal and expected — it does not harm the newborn. This is a common MLE testing point about what the midwife should NOT do after eye prophylaxis.

Scenario

While applying erythromycin eye ointment to a newborn, a relative says 'wash the baby's eyes with water afterward so it doesn't blur the vision.' What should the midwife do?

Solution

The midwife should firmly but kindly explain that the eyes must NOT be irrigated after applying the ointment. The medication needs to remain in contact with the conjunctiva to work. Blurring of vision is expected and temporary.

Applications

Routine post-birth care of every newborn at BHS, lying-in clinic, or home delivery
Parent/family education about why these drugs are given to the newborn
Correct injection technique in the vastus lateralis for newborns
Following the EINC/Unang Yakap care bundle sequence in the delivery room
Recording Vitamin K dose and eye ointment application in the newborn record

Misconceptions

MISCONCEPTION: Vitamin K is given orally to all newborns. TRUTH: The standard route is IM (intramuscular). Oral Vitamin K exists in some countries but IM is the DOH standard in the Philippines.
MISCONCEPTION: The newborn injection site is the buttock. TRUTH: The anterolateral THIGH (vastus lateralis) is the correct site for newborns — the buttock risks sciatic nerve injury.
MISCONCEPTION: Silver nitrate is still the preferred eye prophylaxis agent. TRUTH: Silver nitrate is the HISTORICAL agent; erythromycin 0.5% ophthalmic ointment is now preferred.
MISCONCEPTION: Eye ointment should be applied immediately at birth, before skin-to-skin. TRUTH: Initial bonding (skin-to-skin, eye-to-eye contact) happens FIRST; eye ointment is applied as part of the later post-birth care bundle.

Related Concepts

EINC (Essential Intrapartum and Newborn Care) / Unang Yakap protocol
VKDB (Vitamin K Deficiency Bleeding) — formerly Hemorrhagic Disease of the Newborn
Ophthalmia neonatorum — gonococcal and chlamydial neonatal conjunctivitis
Clotting factors II, VII, IX, X — Vitamin K dependent
Unang Yakap steps: dry, skin-to-skin, cord clamp, breastfeed, Vit K, eye ointment, BCG/HBV vaccine

Common Exam Questions

Example

A 1.8 kg term newborn should receive Vitamin K1 at a dose of: A) 0.5 mg IM B) 1 mg IM C) 1 mg IV D) 0.5 mg oral. ANSWER: B — 1 mg IM (birth weight ≥ 1.5 kg, term)

Approach

The dividing line is birth weight 1.5 kg. Less than 1.5 kg = 0.5 mg; 1.5 kg and above = 1 mg. Practice identifying this quickly.

Question Type

Dose Selection (Preterm vs. Term)

Example

The DOH-preferred agent for prevention of ophthalmia neonatorum in the Philippines is: A) Silver nitrate 1% B) Tetracycline 1% ointment C) Erythromycin 0.5% ophthalmic ointment D) Penicillin eye drops. ANSWER: C

Approach

The MLE may list silver nitrate, erythromycin, tetracycline, and other options. Know that the DOH-PREFERRED current agent is ERYTHROMYCIN 0.5% ophthalmic ointment.

Question Type

Correct Agent Identification

Example

After applying erythromycin ophthalmic ointment to a newborn's eyes, the midwife should: A) Irrigate each eye with saline B) Wipe excess with a cotton ball C) Not irrigate the eyes D) Apply the ointment again in 1 hour. ANSWER: C

Approach

Questions may test what NOT to do after eye prophylaxis — the answer is always: do NOT irrigate the eyes.

Question Type

Post-procedure Instruction

Key Points To Remember

Vitamin K1 prevents VKDB (Vitamin K Deficiency Bleeding) — formerly called Hemorrhagic Disease of the Newborn
TERM (≥ 1.5 kg): Vitamin K1 1 mg IM; PRETERM (< 1.5 kg): 0.5 mg IM
Injection site for newborn: ANTEROLATERAL THIGH (vastus lateralis) — NOT the buttock
Eye prophylaxis prevents OPHTHALMIA NEONATORUM (gonococcal/chlamydial conjunctivitis)
DOH preferred agent: ERYTHROMYCIN 0.5% ophthalmic ointment
Applied into the LOWER CONJUNCTIVAL SAC of each eye
Do NOT irrigate the eyes after applying — this removes the ointment
Silver nitrate is the HISTORICAL agent — now largely REPLACED by erythromycin ointment
Both are given within the first hour as part of EINC/Unang Yakap essential newborn care
Given AFTER initial bonding/skin-to-skin — bonding is not interrupted for these procedures

Micronutrient Supplements — Iron, Folic Acid, and Vitamin A

Micronutrient supplementation is a ROUTINE antenatal and postpartum intervention that the midwife dispenses at every prenatal visit at the BHS or RHU. These are not therapeutic drugs for disease — they are PREVENTIVE supplements to support the extraordinary nutritional demands of pregnancy, protect against neural tube defects, and prevent/treat iron deficiency anemia. --- IRON + FOLIC ACID (Ferrous Sulfate + Folic Acid) --- Every pregnant woman receives: - 60 mg ELEMENTAL IRON + 400 micrograms (0.4 mg) FOLIC ACID - ONCE DAILY throughout the ENTIRE pregnancy - CONTINUED for 3 MONTHS POSTPARTUM WHY IRON? Pregnancy dramatically increases blood volume and red cell mass — the mother's iron needs triple. Iron deficiency anemia is one of the most common nutritional problems in Filipino pregnant women. Severe anemia increases risks of preterm birth, low birth weight, PPH, and maternal death. WHY FOLIC ACID? Folic acid must be started BEFORE conception and in early pregnancy to prevent NEURAL TUBE DEFECTS (NTDs) like spina bifida and anencephaly. The neural tube closes at around 28 days post-conception (often before the woman even knows she is pregnant). Ideally, folic acid supplementation should begin AT LEAST ONE MONTH before pregnancy. For ANEMIC WOMEN: The iron dose may be increased to TWICE DAILY under protocol. The midwife should screen for anemia at every ANC visit using pallor of conjunctiva/palms/tongue and hemoglobin measurement (if available). Women with severe anemia (Hgb < 7 g/dL) or non-response to oral iron should be REFERRED. --- VITAMIN A --- PREGNANCY: HIGH-DOSE Vitamin A is ABSOLUTELY CONTRAINDICATED during pregnancy due to TERATOGENICITY. Excessive Vitamin A can cause severe fetal malformations (cranial, cardiac, thymic defects). Pregnant women should be counseled NEVER to take high-dose Vitamin A supplements. POSTPARTUM: A single dose of VITAMIN A 200,000 IU capsule is given to postpartum women within the first weeks after delivery, according to current DOH policy. This replenishes the mother's Vitamin A stores depleted by pregnancy and supports immune function. BREASTFEEDING: Since high-dose Vitamin A is given postpartum (not during pregnancy), the small amount that passes into breast milk benefits the newborn — this is actually one of the reasons for giving it postpartum rather than during pregnancy.

Examples

Hemoglobin of 9 g/dL indicates moderate anemia in pregnancy. The standard dose is doubled for anemic women. Anemia in pregnancy increases risk of PPH, preterm birth, and low birth weight — early detection and treatment at the BHS/RHU level is within the midwife's scope. Non-response or severe anemia requires physician referral.

Scenario

A G2P1 woman at 10 weeks AOG comes for her first prenatal visit at the RHU. She looks pale, her palms are pale, and her conjunctivae are pale. Her hemoglobin is 9 g/dL. What should the midwife do regarding iron supplementation?

Solution

The midwife should give FERROUS SULFATE + FOLIC ACID at TWICE DAILY dosing (120 mg elemental iron + 400 mcg folic acid twice daily) for anemia, per protocol. She should schedule a return visit in 4 weeks to reassess hemoglobin. If no improvement after adequate treatment, or if Hgb drops below 7 g/dL, she should REFER to the physician.

The neural tube closes at 28 days post-conception — before most women know they are pregnant. To be effective, folic acid must be in the woman's system BEFORE conception. This is called preconceptional folic acid supplementation and is a standard family-planning and prenatal counseling recommendation.

Scenario

A 25-year-old woman is planning to get pregnant in 3 months. She asks the midwife if there is anything she should take now to protect her future baby. What is the most important supplement to recommend?

Solution

FOLIC ACID 400 mcg (0.4 mg) daily, starting NOW — at least 1 month before conception. This is the most important preconceptional supplement to prevent neural tube defects like spina bifida and anencephaly.

Applications

Dispensing iron-folic acid tablets at every antenatal visit at BHS/RHU
Counseling pregnant women on why supplements are important and how to take them correctly
Anemia screening at ANC visits and decision to double iron dose
Counseling women planning pregnancy to start folic acid before conception
Postpartum Vitamin A supplementation per current DOH policy
Food-drug interaction counseling: Vitamin C with iron, avoid tea/coffee near iron dose

Misconceptions

MISCONCEPTION: Iron supplementation is stopped at delivery. TRUTH: Continue for 3 MONTHS POSTPARTUM to replenish stores depleted during pregnancy and delivery.
MISCONCEPTION: All Vitamin A supplements are safe in pregnancy. TRUTH: HIGH-DOSE Vitamin A (like the 200,000 IU postpartum capsule) is TERATOGENIC and CONTRAINDICATED during pregnancy.
MISCONCEPTION: Folic acid is only important in the first trimester. TRUTH: While neural tube protection requires folic acid BEFORE conception and in early pregnancy, folic acid supplementation continues throughout pregnancy as part of the standard iron-folic acid combination.
MISCONCEPTION: Dark stools after taking iron tablets mean internal bleeding. TRUTH: Dark/black stools are a NORMAL and expected side effect of iron supplementation — counsel women about this to prevent unnecessary anxiety and non-compliance.

Related Concepts

Anemia in pregnancy — classification (mild, moderate, severe)
Neural tube defects — spina bifida, anencephaly, encephalocele
DOH Antenatal Care program — routine prenatal supplements
Breastfeeding and maternal nutrition
MNCHN Program — micronutrient supplementation components

Common Exam Questions

Example

The standard iron supplementation for a non-anemic pregnant woman is: A) 30 mg once daily B) 60 mg elemental iron + 0.4 mg folic acid once daily C) 120 mg twice daily D) 60 mg three times daily. ANSWER: B

Approach

The standard dose numbers are frequently tested: 60 mg iron, 400 mcg (0.4 mg) folic acid, once daily. Know these precisely.

Question Type

Dose Recall

Example

Iron and folic acid supplementation during pregnancy should be continued for how long postpartum? A) 1 month B) 6 months C) 3 months D) Until breastfeeding stops. ANSWER: C

Approach

A common trap is asking about DURATION — many students forget the 3-month postpartum continuation. The supplement does not stop at delivery.

Question Type

Duration

Example

A pregnant woman asks about taking a Vitamin A 200,000 IU capsule given to her by a health worker. The midwife should: A) Allow it — Vitamin A is safe B) Advise her NOT to take it — high-dose Vitamin A is teratogenic in pregnancy C) Give half the dose D) Give it orally instead. ANSWER: B

Approach

Any question involving Vitamin A and pregnancy should trigger the teratogenicity alert — high dose is CONTRAINDICATED.

Question Type

Teratogenicity Warning

Key Points To Remember

Iron + Folic Acid: 60 mg elemental iron + 400 mcg folic acid ONCE DAILY throughout pregnancy
Continue iron + folic acid for 3 MONTHS POSTPARTUM
For anemic women: increase iron to TWICE DAILY under protocol
Folic acid prevents NEURAL TUBE DEFECTS (spina bifida, anencephaly)
Ideally start folic acid at least 1 MONTH BEFORE CONCEPTION
HIGH-DOSE Vitamin A is CONTRAINDICATED IN PREGNANCY (teratogenic)
Postpartum Vitamin A: 200,000 IU single dose (per DOH policy, within weeks of delivery)
Severe anemia (Hgb < 7 g/dL) or non-response to oral iron = REFER
Ferrous sulfate may cause side effects: dark stools, constipation, nausea — counsel accordingly
Iron is best absorbed on an empty stomach; Vitamin C enhances absorption; tea/calcium reduces absorption

Tetanus-Diphtheria (Td) Vaccination in Pregnancy

Neonatal tetanus is a devastating, vaccine-preventable disease where the newborn develops tetanic spasms due to infection of the umbilical cord stump with Clostridium tetani, typically from unsterile delivery practices. The midwife plays a KEY ROLE in eliminating neonatal tetanus by administering tetanus-containing vaccines to pregnant women during antenatal visits. Under current DOH policy, the vaccine given is TETANUS-DIPHTHERIA (Td), which protects against BOTH tetanus AND diphtheria. The classic immunization logic uses the TT1–TT5 (Tetanus Toxoid) framework: Each dose is: 0.5 mL IM into the DELTOID muscle THE TT1–TT5 SCHEDULE: - Td1: Given as EARLY AS POSSIBLE in pregnancy (at first prenatal contact) — provides NO immediate protection but starts the immune response - Td2: At least 4 WEEKS after Td1 — provides protection for about 3 YEARS and covers THAT PREGNANCY - Td3: At least 6 MONTHS after Td2 — extends protection to about 5 YEARS - Td4: At least 1 YEAR after Td3 — extends protection to about 10 YEARS - Td5: At least 1 YEAR after Td4 — provides LIFETIME PROTECTION / covers ALL CHILDBEARING YEARS A woman who has completed 5 doses of tetanus-containing vaccine (the full Td1–Td5 series) is considered FULLY IMMUNIZED — her newborn is protected against neonatal tetanus through maternal antibodies transferred across the placenta. KEY POINT: The midwife checks each pregnant woman's immunization history at the FIRST prenatal visit. If she has received previous doses (from childhood EPI or previous pregnancies), she picks up from where she left off. She does NOT need to restart the series from Td1. Women who are already fully immunized (Td5 complete) do NOT need further doses in subsequent pregnancies — they are protected for life.

Examples

Since Maria has no previous tetanus immunization history, she starts at Td1. The critical goal is to complete at least Td2 before delivery to protect the current pregnancy. Td2 must be given at least 2 weeks before delivery to allow adequate antibody formation. The midwife should track this on the woman's MCH record.

Scenario

Maria, a 22-year-old primigravida, comes for her first prenatal visit at 12 weeks AOG. She has no record of any previous tetanus immunization. What is the midwife's plan for Td vaccination?

Solution

Give Td1 TODAY (at this first prenatal visit). Schedule Td2 at least 4 weeks later (at the next prenatal visit). Td2 is the minimum needed to protect this pregnancy. If time allows, continue with Td3, Td4, Td5 in subsequent contacts to build up long-term protection.

The midwife does NOT restart from Td1 — she picks up from where the woman left off. Td3 was given 3 years ago; the interval requirement for Td4 is at least 1 year after Td3, which has been met. This is correct continuity of immunization.

Scenario

A 30-year-old G3P2 woman comes for ANC. She shows her immunization card showing she received Td1 and Td2 during her first pregnancy (5 years ago), and Td3 during her second pregnancy (3 years ago). What dose should she receive now?

Solution

She should receive Td4 now (since Td3 was given 3 years ago, more than 1 year has elapsed — she is due for Td4). She then needs Td5 at least 1 year after Td4 to complete her full immunization.

Applications

Assessing and recording Td immunization status at first prenatal visit
Administering Td doses and recording in the woman's MCH record and the barangay immunization register
Counseling pregnant women on the importance of completing the Td schedule
Continuing immunization from the last received dose — not restarting unnecessarily
Community immunization outreach for women of childbearing age

Misconceptions

MISCONCEPTION: Td vaccination during pregnancy is dangerous for the fetus. TRUTH: Td is SAFE during pregnancy and is a ROUTINE part of antenatal care. It protects both mother and newborn.
MISCONCEPTION: If a woman missed some doses years ago, she must restart from Td1. TRUTH: The schedule is CONTINUED from the last received dose — there is no need to restart, regardless of how long ago the last dose was given.
MISCONCEPTION: Td1 alone protects the current pregnancy. TRUTH: Td1 alone provides NO protection. The minimum for the current pregnancy is Td2, given at least 4 weeks after Td1.
MISCONCEPTION: The midwife gives Td into the thigh. TRUTH: The Td injection site for adults/pregnant women is the DELTOID (upper arm). The thigh (vastus lateralis) is for NEWBORNS.

Related Concepts

Neonatal tetanus — pathophysiology and prevention
DOH Expanded Program on Immunization (EPI)
Maternal and Neonatal Tetanus Elimination (MNTE) program
Antenatal care visits and immunization schedule
Cold chain requirements for vaccines
Maternal antibody transfer — passive immunity for the newborn

Common Exam Questions

Example

The interval between Td3 and Td4 is at least: A) 4 weeks B) 6 months C) 1 year D) 2 years. ANSWER: C

Approach

The intervals between doses are testable: Td1→Td2 = 4 weeks; Td2→Td3 = 6 months; Td3→Td4 = 1 year; Td4→Td5 = 1 year. Know these.

Question Type

Schedule Recall

Example

Which Td dose is the MINIMUM required to protect a pregnant woman's current pregnancy against neonatal tetanus? A) Td1 B) Td2 C) Td3 D) Td5. ANSWER: B

Approach

Know which dose FIRST provides protection for the current pregnancy — it is Td2. Td1 alone provides NO protection.

Question Type

Protection Assessment

Example

A woman with a complete history of 5 Td doses presents for ANC in her third pregnancy. How many Td doses does she need? A) 1 dose B) 2 doses C) 3 doses D) None — she is fully immunized. ANSWER: D

Approach

5 doses = fully immunized = lifetime protection. A woman with 5 previous doses does NOT need any more Td in future pregnancies.

Question Type

Fully Immunized Status

Key Points To Remember

Current DOH vaccine: TETANUS-DIPHTHERIA (Td) — not just tetanus toxoid alone
Dose: 0.5 mL IM into the DELTOID muscle
Td1: Start as early as possible in pregnancy — NO protection yet
Td2: ≥ 4 weeks after Td1 — protects for ~3 years; covers THAT PREGNANCY
Td3: ≥ 6 months after Td2 — protects for ~5 years
Td4: ≥ 1 year after Td3 — protects for ~10 years
Td5: ≥ 1 year after Td4 — LIFETIME protection; covers all childbearing years
Td2 is the MINIMUM requirement to protect the current pregnancy
5 doses = FULLY IMMUNIZED = LIFETIME protection
Check immunization history at first prenatal visit — continue from last received dose, do not restart
Protection transfers to newborn via MATERNAL ANTIBODIES across the placenta

Family Planning — Contraceptive Methods Within the Midwife's Scope

Family planning (FP) is a core component of the midwife's primary-care services under the DOH MNCHN (Maternal, Newborn, Child Health and Nutrition) program. The midwife provides COUNSELING and administers or dispenses the following contraceptive methods: 1. COMBINED ORAL CONTRACEPTIVES (COCs) 2. PROGESTIN-ONLY PILLS (POPs, the 'Mini-pill') 3. INJECTABLE CONTRACEPTIVES (DMPA) 4. CONDOMS (male and female) 5. COUNSELING and REFERRAL for IUD and implants (insertion requires specific certification) --- COMBINED ORAL CONTRACEPTIVES (COCs) --- Contain: ESTROGEN + PROGESTIN Mechanism: Prevent ovulation, thicken cervical mucus, change endometrial lining CONTRAINDICATIONS (WHO Medical Eligibility Criteria — MEC 3 or 4): - SMOKING + age ≥ 35 years (cardiovascular risk) - UNCONTROLLED HYPERTENSION - History of THROMBOEMBOLISM (DVT, PE, stroke) - BREASTFEEDING women < 6 months postpartum (estrogen reduces milk supply) - Severe liver disease, active migraines with aura During BREASTFEEDING: COCs are NOT the first choice for lactating women (estrogen can reduce milk supply). Preferred alternatives are POPs or DMPA. --- PROGESTIN-ONLY PILLS (POPs / Mini-pill) --- Contain: PROGESTIN ONLY (no estrogen) Mechanism: Thicken cervical mucus (primary), may suppress ovulation Advantage: SAFE FOR BREASTFEEDING WOMEN — does not reduce milk supply Must be taken at the SAME TIME every day (strict timing — window is only 3 hours) --- DMPA (DEPOT MEDROXYPROGESTERONE ACETATE) --- Dose: 150 mg IM every 3 MONTHS (every 12 weeks / 13 weeks) Route: Deep IM injection (gluteal or deltoid muscle) Advantage: Long-acting, does not require daily compliance, SAFE for breastfeeding Side effects to counsel: Irregular bleeding/spotting, amenorrhea with prolonged use, delayed return to fertility (months after stopping) The midwife must verify that the woman is NOT pregnant before giving DMPA. --- IUD AND IMPLANTS --- The midwife may provide COUNSELING and REFERRAL for intrauterine devices (IUDs) and implants. INSERTION requires specific additional training and certification — this is NOT a routine procedure for all midwives.

Examples

COCs contain estrogen, which can DECREASE BREAST MILK SUPPLY — this is a significant concern for a woman who is exclusively breastfeeding a 2-month-old. POPs contain progestin only and do not affect lactation. This clinical scenario is frequently tested in the MLE.

Scenario

A 28-year-old woman who delivered 2 months ago and is exclusively breastfeeding comes to the BHS requesting contraception. She prefers a pill. Which type should the midwife recommend?

Solution

The midwife should recommend PROGESTIN-ONLY PILLS (POPs/Mini-pill) — NOT combined oral contraceptives. POPs are safe for breastfeeding women because they contain no estrogen, which is the component that reduces milk supply. DMPA injectable is also an excellent option if she prefers less frequent dosing.

Smoking + age ≥ 35 is a WHO MEC Category 4 contraindication (unacceptable health risk) for COC use. The midwife screens for this contraindication BEFORE providing COCs. Offering alternative methods is the appropriate action.

Scenario

A 38-year-old woman who smokes 1 pack per day comes to the RHU requesting oral contraceptives. She has no other medical history. What should the midwife do?

Solution

The midwife should NOT provide combined oral contraceptives (COCs) to this woman. She should counsel her about the significantly increased cardiovascular risk (thromboembolism, stroke) from COCs in women who smoke AND are aged 35 or older. She should offer alternative methods such as POPs, DMPA, condoms, or refer for IUD counseling.

Applications

FP counseling at postpartum visits (immediate and extended postpartum FP)
Screening for COC/DMPA contraindications before dispensing/administering
DMPA injection at the BHS/RHU every 3 months
Breastfeeding-compatible FP method selection
Referral for IUD insertion and implant insertion to trained providers
Recording FP acceptance and method used in FHSIS registers

Misconceptions

MISCONCEPTION: All oral contraceptive pills are the same. TRUTH: COCs (combined) and POPs (progestin-only) have DIFFERENT compositions, mechanisms, and contraindications. They are NOT interchangeable, especially for breastfeeding women.
MISCONCEPTION: IUD insertion is a routine midwife procedure. TRUTH: IUD and implant INSERTION requires SPECIFIC ADDITIONAL TRAINING and certification — not all midwives are authorized to do this.
MISCONCEPTION: DMPA can be given without first checking for pregnancy. TRUTH: The midwife must RULE OUT PREGNANCY before giving DMPA — giving it during unrecognized early pregnancy is a concern.
MISCONCEPTION: Condoms are only for STI prevention, not contraception. TRUTH: Condoms are EFFECTIVE contraceptives AND the ONLY method that provides dual protection against both pregnancy AND STIs/HIV.

Related Concepts

WHO Medical Eligibility Criteria (MEC) for contraceptive use
Postpartum family planning (PPFP)
Lactational Amenorrhea Method (LAM) — natural FP during breastfeeding
MNCHN Program — FP as a component of maternal health
Informed consent and FP counseling
Calendar/rhythm method — natural family planning

Common Exam Questions

Example

A breastfeeding mother at 3 months postpartum wants contraception. The BEST choice is: A) Combined oral contraceptives B) Progestin-only pills C) COCs with low estrogen D) Any oral contraceptive. ANSWER: B

Approach

Always choose progestin-only methods (POPs or DMPA) for breastfeeding women. Eliminate COCs first.

Question Type

Breastfeeding Compatibility

Example

The correct dose and frequency of DMPA for contraception is: A) 100 mg IM monthly B) 150 mg IM every 3 months C) 150 mg IM monthly D) 300 mg IM every 6 months. ANSWER: B

Approach

DMPA dose and frequency are frequently tested: 150 mg IM every 3 months. Note both the dose AND the interval.

Question Type

DMPA Dosing

Example

Which of the following is a contraindication to COC use? A) Age 25, non-smoker B) Regular menstrual cycles C) History of deep vein thrombosis D) Mild iron deficiency anemia. ANSWER: C

Approach

Match contraindications with the correct drug: hypertension/smoking/thromboembolism = NO COCs. For DMPA, rule out pregnancy first.

Question Type

Contraindication Matching

Key Points To Remember

COCs: estrogen + progestin — CONTRAINDICATED in smokers ≥35 y/o, uncontrolled hypertension, thromboembolism history, breastfeeding < 6 months
POPs: progestin only — SAFE for breastfeeding; must be taken at the SAME TIME every day
DMPA: 150 mg IM every 3 MONTHS — safe for breastfeeding, long-acting
During breastfeeding: prefer POPs or DMPA over COCs (estrogen reduces milk supply)
IUD and implant INSERTION requires specific training/certification — midwife COUNSELS and REFERS for insertion
Rule out pregnancy BEFORE giving DMPA
DMPA delayed return to fertility — counsel women who plan future pregnancy
Condoms: only method that protects against BOTH pregnancy AND STIs/HIV
Counsel on WHO Medical Eligibility Criteria (MEC) — screen for contraindications before providing hormonal methods

Magnesium Sulfate (MgSO4) — The Emergency Anticonvulsant Loading Dose

Pre-eclampsia and eclampsia are life-threatening complications of pregnancy. ECLAMPSIA (seizures in a pregnant/postpartum woman with hypertension) is a leading cause of maternal death. The midwife's role is to DETECT these conditions early and REFER — but when a seizure has already occurred or is imminent (severe pre-eclampsia), she may give the LOADING DOSE of magnesium sulfate (MgSO4) as a LIFE-SAVING FIRST-AID MEASURE before and during referral. This is the ONE EMERGENCY ANTICONVULSANT in the midwife's formulary — and it is HEAVILY TESTED. --- THE LOADING DOSE (Magpie/Zuspan-based regimen) --- Give SIMULTANEOUSLY: 1. IV COMPONENT: 4 g of MgSO4 (20% solution = 20 mL) slow IV over 5–20 MINUTES 2. IM COMPONENT: 5 g of MgSO4 (50% solution) + 1 mL 2% lignocaine in EACH BUTTOCK (10 g total IM) Total loading dose = 4 g IV + 10 g IM = 14 g MgSO4 WHY LIGNOCAINE WITH THE IM DOSE? MgSO4 50% injection is very irritating and PAINFUL at the IM site. Mixing 1 mL of 2% lignocaine (lidocaine) with each 5g IM dose reduces the pain significantly. --- THE MAINTENANCE DOSE --- (NOT the midwife's responsibility!) 5 g MgSO4 IM every 4 hours in ALTERNATE buttocks — this is given by the physician at the referral facility. The midwife gives the LOADING DOSE ONLY, then REFERS IMMEDIATELY. --- SAFETY MONITORING (3 CRITICAL PARAMETERS) --- Before and between MgSO4 doses, check ALL THREE: 1. RESPIRATORY RATE: must be ≥ 12–16 breaths/minute (respiratory depression is a key sign of toxicity) 2. URINE OUTPUT: must be ≥ 30 mL/hour (or ≥ 100 mL per 4 hours) — MgSO4 is excreted by kidneys 3. PATELLAR (KNEE-JERK) REFLEX: must be PRESENT — loss of patellar reflex is the EARLIEST sign of MgSO4 toxicity If ANY of these thresholds is NOT MET: STOP MgSO4 --- ANTIDOTE FOR MGSO4 TOXICITY --- CALCIUM GLUCONATE 1 g IV (= 10 mL of 10% solution) slow IV push Must be immediately available whenever MgSO4 is being given! --- HOW MGSO4 PREVENTS SEIZURES --- MgSO4 is NOT a traditional anticonvulsant like phenytoin or diazepam. It works by: - Blocking NMDA receptors in the brain - Reducing cerebral vasospasm - Stabilizing neuronal membranes - Its specific anticonvulsant effect in eclampsia is better than any other agent for this condition

Examples

This is eclampsia (seizure + hypertension in pregnancy). The midwife's role is STABILIZE and REFER — not manage independently. The MgSO4 loading dose is a LIFE-SAVING first-aid measure given BEFORE and DURING transport. The maintenance dose and further management is at the hospital. This scenario is one of the highest-priority items in the MLE.

Scenario

A midwife at a BHS is attending a 32-week pregnant woman who suddenly has a convulsion. She has a BP of 160/110 mmHg. The midwife has MgSO4 available. What should she do?

Solution

IMMEDIATE ACTIONS: (1) Protect the woman from injury during the seizure. (2) Call for help and arrange URGENT REFERRAL to hospital immediately. (3) After the seizure stops, give the MgSO4 LOADING DOSE: 4 g IV (20% solution) slowly over 5–20 minutes + 5 g IM into each buttock (10 g total, each mixed with 1 mL of 2% lignocaine). (4) Check safety parameters: RR, urine output, patellar reflexes. (5) Transport to hospital immediately — do not wait for another seizure.

Respiratory rate of 10/min (below the threshold of 12/min) AND absent patellar reflex are both signs of MgSO4 TOXICITY. The antidote is calcium gluconate. This is why calcium gluconate must ALWAYS be at the bedside whenever MgSO4 is being used. The knee-jerk reflex is the EARLIEST warning sign — its absence means dangerous blood levels are being reached.

Scenario

During administration of MgSO4 maintenance dose at a BHS (midwife assisting the doctor who just arrived), the midwife notes the patient's respiratory rate is 10 breaths per minute and the knee-jerk reflex is absent. What should be done?

Solution

STOP MgSO4 IMMEDIATELY. Give CALCIUM GLUCONATE 1 g (10 mL of 10% solution) SLOW IV PUSH as the antidote. Administer oxygen. Continue monitoring. Urgent referral if not already at a higher-level facility.

Applications

Emergency management of eclampsia at BHS/lying-in before referral
Pre-referral loading dose of MgSO4 for severe pre-eclampsia/imminent eclampsia
Safety monitoring before and between doses
Having calcium gluconate available as antidote whenever MgSO4 is used
Clear documentation of time, dose, route, and response
Monitoring urine output with a catheter during MgSO4 administration

Misconceptions

MISCONCEPTION: The midwife gives both the loading dose AND the maintenance dose. TRUTH: The midwife gives the LOADING DOSE ONLY as a pre-referral first-aid measure. The maintenance dose is given by the physician at the referral facility.
MISCONCEPTION: Diazepam (Valium) is the drug of choice for eclamptic seizures. TRUTH: MAGNESIUM SULFATE is SUPERIOR to diazepam for eclampsia — it is the international standard of care for preventing and treating eclamptic seizures.
MISCONCEPTION: Loss of knee-jerk reflex is a late sign of toxicity. TRUTH: Loss of patellar reflex is the EARLIEST sign — it occurs before respiratory depression and cardiac arrest. This is why patellar reflex monitoring is so critical.
MISCONCEPTION: MgSO4 is a sedative/anticonvulsant like diazepam. TRUTH: MgSO4 is a MINERAL (magnesium salt) that works via a specific mechanism (NMDA receptor blockade, reducing cerebral vasospasm) — it is not a sedative and does not cause sedation at therapeutic doses.

Related Concepts

Pre-eclampsia and eclampsia — definition, signs, and symptoms
BEmONC signal function — administration of loading dose MgSO4
Hypertensive disorders of pregnancy (HDP) — WHO classification
Danger signs in pregnancy requiring immediate referral
Urine output monitoring — catheter placement in eclampsia
Calcium gluconate — mechanism as MgSO4 antidote (competitive antagonism)

Common Exam Questions

Example

The MgSO4 loading dose for eclampsia includes: A) 2 g IV only B) 4 g IV over 5-20 min plus 5 g deep IM in each buttock C) 10 g IV over 1 hour D) 5 g IM in one buttock. ANSWER: B

Approach

Memorize: 4 g IV (20% solution) over 5-20 min + 10 g IM (5 g each buttock, 50% solution + lignocaine). Both IV and IM components are given SIMULTANEOUSLY for loading.

Question Type

Loading Dose Recall (Most Tested)

Example

Before giving a dose of MgSO4, the midwife checks that: A) Blood pressure is below 140/90 B) Respiratory rate is ≥12/min, urine output ≥30 mL/hr, and patellar reflex is present C) The woman has not eaten in 2 hours D) Fetal heart rate is normal. ANSWER: B

Approach

The THREE parameters are tested as a set. Know ALL three: respiratory rate, urine output, patellar reflex. ANY one abnormal = stop MgSO4.

Question Type

Safety Monitoring

Example

The antidote for magnesium sulfate toxicity is: A) Potassium chloride IV B) Calcium gluconate 1 g slow IV C) Diazepam 10 mg IV D) Calcium carbonate oral. ANSWER: B

Approach

MgSO4 toxicity antidote = CALCIUM GLUCONATE 1 g IV. Do not confuse with calcium chloride or potassium.

Question Type

Antidote Identification

Key Points To Remember

MgSO4 is the ONLY emergency anticonvulsant in the midwife's formulary — for eclampsia/severe pre-eclampsia
LOADING DOSE: 4 g IV (20% solution) over 5–20 min + 10 g IM (5 g each buttock, 50% solution + 1 mL 2% lignocaine each side)
Lignocaine is mixed with IM dose to REDUCE PAIN at injection site
MAINTENANCE DOSE (5 g IM every 4 hours) = PHYSICIAN responsibility at referral facility
The midwife gives LOADING DOSE ONLY then REFERS IMMEDIATELY
THREE safety monitoring parameters: RR ≥ 12–16/min, Urine ≥ 30 mL/hr, Patellar reflex PRESENT
Loss of patellar reflex = EARLIEST sign of MgSO4 toxicity — STOP the drug
ANTIDOTE: Calcium gluconate 1 g (10 mL of 10%) slow IV
Calcium gluconate must be READY at bedside whenever MgSO4 is in use
MgSO4 is NOT a traditional sedative/anticonvulsant — it works via NMDA receptor blockade and reduces cerebral vasospasm

Safe Drug Administration Principles and Cold Chain

Whatever the drug, safe administration follows a universal set of principles that apply at every BHS, RHU, and lying-in clinic. The midwife must observe these in practice AND know them for the MLE. --- THE 'RIGHTS' OF MEDICATION --- The classic checklist before ANY drug administration: 1. Right PATIENT — verify identity (name, record) 2. Right DRUG — check label, generic name, concentration 3. Right DOSE — calculate and confirm the correct dose 4. Right ROUTE — IM, IV, oral, ophthalmic — use the specified route 5. Right TIME — correct timing (e.g., oxytocin within 1 minute of birth) 6. Right DOCUMENTATION — record immediately after administration 7. Check for ALLERGIES — ask about drug allergies before every injection 8. Check EXPIRY DATE — never use expired drugs --- COLD CHAIN FOR VACCINES AND OXYTOCIN --- Cold chain refers to the system of temperature-controlled storage and transport needed to maintain the potency of vaccines and some drugs. VACCINES (BCG, OPV, measles, Td, etc.): Stored at 2–8°C in the refrigerator at BHS/RHU level. The BHS midwife is responsible for cold chain monitoring (temperature logs, ice pack management, vaccine vial monitor/VVM). OXYTOCIN: Ideally stored at 2–8°C (cold chain). Exposure to heat degrades oxytocin and reduces its effectiveness — this is why misoprostol is preferred in areas without reliable cold chain. --- INJECTION SITE SELECTION --- - VACCINES and Td for adults/pregnant women: DELTOID (upper arm) - NEWBORN injections (Vitamin K, HBV vaccine): ANTEROLATERAL THIGH (vastus lateralis) - DMPA injectable contraceptive: Deep IM — gluteal or deltoid - MgSO4 loading IM: Deep IM into each BUTTOCK (gluteal muscle) --- ANAPHYLAXIS PREPAREDNESS --- After ANY injection, the midwife observes the patient for at least 15–30 minutes for signs of anaphylaxis: - Signs: sudden urticaria, swelling (throat, face), difficulty breathing, hypotension, tachycardia, collapse - Treatment: ADRENALINE (EPINEPHRINE) 0.5 mg (0.5 mL of 1:1000 solution) IM immediately - Having adrenaline available is MANDATORY before giving any injection --- SHARPS DISPOSAL --- Used needles are NEVER recapped (to prevent needle-stick injuries). Dispose in a puncture-resistant container (sharps box). Proper waste segregation per DOH guidelines.

Examples

The Vaccine Vial Monitor (VVM) is a heat-sensitive label attached to vaccine vials. When the inner disc darkens to match or exceed the outer ring, the vaccine has been exposed to excessive heat and its potency is compromised. Never give a vaccine with a failed VVM — it provides false protection and wastes the opportunity for real immunization.

Scenario

A midwife is about to give Td vaccination to a pregnant woman. She checks the vaccine vial and notices the VVM (Vaccine Vial Monitor) disc has changed to a dark color matching the outer ring. What should she do?

Solution

Do NOT use this vaccine. The VVM color change indicates the vaccine has been HEAT DAMAGED and is no longer potent. The midwife should discard this vial, report the cold chain failure, and use a viable vial from proper cold storage if available. Document the incident and reschedule if a replacement vaccine is unavailable.

Applications

Pre-injection checklist at every drug administration
Cold chain monitoring at BHS — daily temperature logs
Correct injection site selection for different drugs and patient populations
Post-injection observation for anaphylaxis
Sharps disposal and infection prevention
Documentation in maternal/newborn records and FHSIS forms

Misconceptions

MISCONCEPTION: Vaccines can be kept at room temperature for a day or two without losing potency. TRUTH: Most vaccines are damaged by heat — cold chain maintenance is essential for potency.
MISCONCEPTION: Recap needles to keep them clean for disposal. TRUTH: NEVER recap needles — this is the most common cause of needle-stick injuries in healthcare workers. Drop directly into sharps container.
MISCONCEPTION: Document drug administration later when there is time. TRUTH: Document IMMEDIATELY after each drug administration — 'if it's not documented, it's not done' — delayed documentation leads to errors and double-dosing.

Related Concepts

FHSIS (Field Health Service Information System) recording forms
Infection prevention and control at BHS/lying-in
DOH cold chain management guidelines
Vaccine Vial Monitor (VVM) interpretation
Health waste management — sharps disposal

Common Exam Questions

Example

Before administering an IM injection, a midwife should first: A) Check the expiry date and patient allergies B) Mix the drug with saline C) Warm the drug to room temperature D) Ask the patient to lie down. ANSWER: A

Approach

Know all 7 rights. Questions may ask which is MISSING from a list, or ask what the midwife should check BEFORE giving a drug.

Question Type

Right of Medication

Example

A woman develops severe urticaria, difficulty breathing, and hypotension immediately after a Td injection. The midwife should immediately administer: A) Hydrocortisone IV B) Diphenhydramine IM C) Epinephrine 0.5 mg IM D) Calcium gluconate IV. ANSWER: C

Approach

Know the drug and dose for anaphylaxis: EPINEPHRINE (adrenaline) 0.5 mg IM. This is a life-saving first-aid measure within the midwife's scope.

Question Type

Anaphylaxis Management

Key Points To Remember

7 Rights of medication: Patient, Drug, Dose, Route, Time, Documentation + check Allergies and Expiry
Cold chain: vaccines and oxytocin stored at 2–8°C; never frozen (except OPV which CAN be frozen)
Vaccine Vial Monitor (VVM) checks vaccine viability — if VVM changes color beyond guideline, do not use
DELTOID: Td in adults/pregnant women; ANTEROLATERAL THIGH: newborn injections
Have ADRENALINE (epinephrine) available before every injection — for anaphylaxis
Anaphylaxis treatment: Epinephrine 0.5 mg (0.5 mL of 1:1000) IM
NEVER recap used needles — dispose in sharps container immediately
Record every dose in the mother's/newborn's record AND the FHSIS register
Misoprostol advantage: does NOT require cold chain — use in areas without refrigeration

Practice Problems

This scenario tests the integration of AMTSL and EINC/Unang Yakap newborn care. Key timing: oxytocin within 1 minute to the MOTHER; Vitamin K and eye ointment to the NEWBORN as part of the post-birth care bundle. The 1 mg dose is confirmed because birth weight is 3.2 kg (well above the 1.5 kg threshold). The eye ointment is given AFTER initial skin-to-skin and bonding — not interrupting the first precious minutes of contact.

Problem

A midwife at a lying-in clinic has just delivered a baby at 38 weeks gestation, weight 3.2 kg. The baby cries vigorously and is placed on the mother's chest for skin-to-skin. The midwife has confirmed there is only one baby. (1) What is the FIRST drug she should give and when? (2) What is the complete AMTSL protocol? (3) What newborn drugs should she give and what are the doses?

Solution

(1) OXYTOCIN 10 IU IM — given within ONE MINUTE of birth to the MOTHER (not the baby). (2) AMTSL components: A) Oxytocin 10 IU IM within 1 minute of birth. B) Controlled cord traction with uterine counter-guarding during a contraction (wait for signs of placental separation). C) Uterine massage after delivery of the placenta, then every 15 minutes for 2 hours. (3) Newborn drugs: A) VITAMIN K1 1 mg IM into the anterolateral thigh (left or right vastus lateralis) — 1 mg because birth weight is ≥1.5 kg (term). B) ERYTHROMYCIN 0.5% ophthalmic ointment — a thin ribbon into the lower conjunctival sac of each eye. Do not irrigate eyes afterward.

This is a BEmONC signal function: giving the pre-referral loading dose of MgSO4. The midwife's role ends at the LOADING DOSE and URGENT REFERRAL. The maintenance dose (5 g IM every 4 hours) is a physician responsibility at the receiving facility. The safety parameters (RR, urine, reflex) must be checked before starting the drug and during administration. Calcium gluconate must be at the bedside — if RR falls below 12/min or patellar reflex disappears, STOP MgSO4 and give calcium gluconate 1 g IV.

Problem

A woman G1P0 at 36 weeks AOG is brought to the BHS by her husband. He reports she had a seizure at home. On examination: BP 170/115 mmHg, temperature 37.0°C, PR 88, RR 18/min. She is drowsy but responsive. The midwife has MgSO4 available. What should the midwife do? What is the loading dose? What safety parameters must she monitor?

Solution

DIAGNOSIS: ECLAMPSIA (seizure + severe hypertension in pregnancy) — HIGH-RISK EMERGENCY. IMMEDIATE ACTIONS: (1) CALL FOR HELP — activate referral system IMMEDIATELY. (2) Position patient safely (left lateral), protect airway. (3) Give MgSO4 LOADING DOSE: 4 g IV as 20% solution (20 mL) over 5–20 minutes PLUS 5 g of 50% solution (+ 1 mL of 2% lignocaine) deep IM into the LEFT buttock AND 5 g of 50% solution (+ 1 mL of 2% lignocaine) deep IM into the RIGHT buttock. (4) Monitor SAFETY PARAMETERS: RR must be ≥12–16/min (currently 18 — safe), Urine output ≥30 mL/hr (insert catheter to monitor), Patellar (knee-jerk) reflex must be PRESENT. (5) Have CALCIUM GLUCONATE 1 g (10 mL of 10%) ready as antidote. (6) Transport to hospital IMMEDIATELY — do NOT wait for another seizure or give maintenance dose.

This question tests CONTRAINDICATION SCREENING for FP methods. DVT history eliminates COCs (estrogen increases thrombosis risk). Breastfeeding < 6 months ALSO eliminates COCs (reduces milk supply). The midwife's available progestin-only options (POPs, DMPA) are safe for both conditions. IUD/implant insertion requires specific training — the midwife's role here is counseling and referral.

Problem

A midwife is counseling a 28-year-old woman who delivered 2 months ago and is exclusively breastfeeding. She has a history of deep vein thrombosis (DVT). She wants the most effective contraception available at the BHS. What options can the midwife offer? What method is CONTRAINDICATED? What should she be referred for?

Solution

CONTRAINDICATED: Combined Oral Contraceptives (COCs) — for TWO reasons: (1) History of DVT (thromboembolism) is a WHO MEC Category 4 contraindication for COCs, and (2) Breastfeeding less than 6 months postpartum is a WHO MEC Category 3/4 for COCs (estrogen reduces milk supply). OPTIONS THE MIDWIFE CAN OFFER: (1) PROGESTIN-ONLY PILLS (POPs/Mini-pill) — safe for breastfeeding, no thromboembolism risk from progestin alone at contraceptive doses. (2) DMPA (150 mg IM every 3 months) — safe for breastfeeding, highly effective, long-acting. (3) CONDOMS — safe, dual protection. REFERRAL: For IUD (copper or progestin-releasing) or subdermal implant — these are highly effective long-acting reversible methods that a specially trained provider should insert. The midwife COUNSELS about these options and REFERS to the appropriate trained provider.

Two separate but related clinical issues are combined here: anemia management and Td immunization. For anemia, the rule is: standard dose (once daily) for non-anemic women; DOUBLE DOSE (twice daily) for anemic women under protocol. For Td, start at Td1 since she has no prior history, and the critical goal before delivery is to get at least Td2 in with adequate interval. At 16 weeks, there is time to give Td1 now and Td2 at least 4 weeks later.

Problem

At an antenatal visit, a 19-year-old primigravida at 16 weeks AOG has pallor of the conjunctivae and palms. Her hemoglobin is 8.5 g/dL. She has no previous Td immunization history. What micronutrient supplementation should she receive? What is her Td plan? When should the midwife refer for the anemia?

Solution

IRON-FOLIC ACID FOR ANEMIA: Because Hgb is 8.5 g/dL (moderate anemia in pregnancy), the dose is INCREASED to TWICE DAILY: Ferrous sulfate + folic acid (60 mg elemental iron + 400 mcg folic acid) TWICE DAILY. Reassess Hgb in 4 weeks. If no improvement, or if Hgb falls below 7 g/dL, REFER to physician. Continue supplementation throughout pregnancy and for 3 months postpartum. Td VACCINATION PLAN: Give Td1 TODAY (16 weeks AOG, first contact). Schedule Td2 at least 4 weeks later (around 20 weeks AOG) — Td2 is the MINIMUM to protect this pregnancy. If the woman returns for ANC visits, continue with Td3 (≥6 months after Td2), Td4 (≥1 year after Td3), Td5 (≥1 year after Td4). REFERRAL THRESHOLD: Refer immediately if Hgb < 7 g/dL, if anemia is non-responsive after 4 weeks of treatment, or if there are signs of severe anemia (extreme pallor, dyspnea at rest, tachycardia).

The key discriminator here is the DOSE of Vitamin K — 0.5 mg (not 1 mg) because the baby is preterm with birth weight LESS than 1.5 kg. The general principle for preterm newborns: they are HIGH-RISK and require REFERRAL to a higher-level facility with NICU/neonatal care capabilities. The midwife stabilizes (warmth, Vitamin K, initiating breastfeeding) and REFERS.

Problem

A midwife delivers a baby at 33 weeks gestation (preterm), birth weight 1.2 kg. The baby is breathing but slow — RR 30/min. The mother has agreed to breastfeed. What is the correct Vitamin K dose, site, and amount? What should the midwife do about the preterm newborn's condition overall?

Solution

VITAMIN K DOSE: VITAMIN K1 0.5 mg IM (preterm/low birth weight dose — birth weight 1.2 kg is LESS THAN 1.5 kg threshold). INJECTION SITE: Anterolateral thigh (vastus lateralis) of the newborn. PRETERM NEWBORN MANAGEMENT: A preterm baby at 33 weeks with RR 30/min may initially appear to be breathing, but preterm babies are at high risk for respiratory distress syndrome, hypothermia, hypoglycemia, and infection. The midwife should: (1) Dry thoroughly and maintain warmth (prevent hypothermia — critical for preterm babies). (2) Provide skin-to-skin (Kangaroo Mother Care) with the mother to maintain temperature. (3) Give Vitamin K 0.5 mg IM into the anterolateral thigh. (4) Support initiation of breastfeeding/colostrum feeding. (5) REFER to a hospital with neonatal care capacity for full assessment and management of the preterm newborn — a 33-week, 1.2 kg baby requires specialized neonatal care beyond the BHS/lying-in scope.

Exam Preparation Tips

MASTER the AMTSL protocol in EXACT detail: Oxytocin 10 IU IM within 1 MINUTE of birth (after ruling out 2nd twin), controlled cord traction, uterine massage every 15 minutes for 2 hours. This is the single most tested protocol in Midwifery Pharmacology.
MEMORIZE THE DOSES as specific numbers — the MLE loves precision: Vitamin K1 (1 mg term, 0.5 mg preterm with cutoff at 1.5 kg birth weight), MgSO4 loading (4 g IV + 10 g IM), DMPA (150 mg IM every 3 months), Iron-folic acid (60 mg + 400 mcg daily), Td (0.5 mL IM per dose).
For EVERY drug question, ask yourself: Is this SUPPORTING NORMAL BIRTH/PREVENTING DEFICIENCY or is it TREATING A DISEASE? If treating a disease or complication independently = the midwife REFERS. This one principle can guide you through countless scenario questions.
Ergometrine contraindication is ALWAYS tested — practice immediately eliminating ergometrine as a choice in any scenario involving hypertension, pre-eclampsia, or unknown BP status.
The MgSO4 loading dose is high-yield and multi-component — practice writing it from memory: 4g IV (20% solution) over 5-20 min + 5g deep IM each buttock (50% solution + 1 mL 2% lignocaine each side). PLUS the 3 monitoring parameters (RR ≥12, urine ≥30 mL/hr, patellar reflex present) and antidote (calcium gluconate 1g IV).
For family planning questions, apply the BREASTFEEDING rule immediately: breastfeeding woman = NO COCs (estrogen reduces milk) = choose POPs or DMPA. This eliminates wrong answers quickly.
The Td schedule intervals are frequently tested. Create a mnemonic: Td1→Td2 = 4 WEEKS; Td2→Td3 = 6 MONTHS; Td3→Td4 = 1 YEAR; Td4→Td5 = 1 YEAR. Remember: 5 doses = lifetime protection = fully immunized.
Know what happens AFTER each procedure: After eye ointment = do NOT irrigate. After oxytocin in AMTSL = perform controlled cord traction. After MgSO4 = check safety parameters and REFER. These 'what next' questions are common.
High-dose Vitamin A in pregnancy = TERATOGENIC/CONTRAINDICATED — this is a frequently used trap answer. Always choose 'do not give Vitamin A supplement in pregnancy' for high-dose preparations.
The PPH action priority sequence is testable: REFER/CALL HELP first, then massage, oxytocin, empty bladder, check for tears. Do NOT make giving the drug the very first step in PPH questions.
For injection site questions: DELTOID for adults/pregnant women (Td, vaccines); ANTEROLATERAL THIGH for newborns (Vitamin K, HBV); BUTTOCKS for MgSO4 loading IM. Never confuse these.
The midwife GIVES the MgSO4 LOADING DOSE; the PHYSICIAN gives the MAINTENANCE DOSE. If a question asks who gives the maintenance dose, the answer is always the physician at the referral facility.
Study the FORMULARY as two lists: INSIDE (oxytocin for 3rd stage/PPH, ergometrine 2nd line, misoprostol, Vitamin K, eye ointment, iron-folic acid, Vitamin A postpartum, Td vaccine, FP methods, MgSO4 loading dose) and OUTSIDE (antibiotics for treatment, oxytocin for induction/augmentation, antihypertensives, anesthetics, narcotics, insulin). Knowing what is OUTSIDE is equally important.
Practice timing-based questions: Oxytocin = within 1 MINUTE; Vitamin K and eye ointment = within the first HOUR; Td2 = at least 4 WEEKS after Td1; postpartum Vitamin A = within first weeks after delivery; DMPA = every 3 MONTHS. Timing errors in practice = patient safety failures in real life.
Create clinical scenario practice: given a patient situation (pregnant woman with certain conditions, postpartum woman breastfeeding, eclampsia case, preterm newborn), practice running through EVERY drug decision — which drugs to give, what dose, what route, what to monitor, and when to REFER. The MLE heavily uses integrated clinical scenarios.

Loading diagram…

In summary

The midwife's limited formulary under RA 7392 is small but POWERFUL — and mastering it completely is one of the highest-yield investments you can make in your MLE preparation. Every drug in the formulary serves a SPECIFIC, DEFINED purpose in NORMAL maternal-newborn care: oxytocics prevent and treat PPH (the #1 direct maternal killer), Vitamin K prevents fatal newborn bleeding, eye ointment prevents blindness from infection, iron and folic acid prevent anemia and neural tube defects, Td vaccine eliminates neonatal tetanus, family planning methods support maternal and child health, and MgSO4 loading dose saves lives during the most acute moments of eclampsia. The most important principle you will carry into practice and into the examination room is this: WHEN IN DOUBT, REFER. The midwife is an expert in NORMAL birth — she is not a physician, and her greatest strength is knowing exactly where her scope ends and when to bring in higher-level care. A midwife who gives a drug outside her formulary (oxytocin before delivery of the baby to augment labor, ergometrine to a hypertensive woman, antibiotics for treating infection, or MgSO4 maintenance doses without physician oversight) is not being helpful — she is creating danger. Conversely, a midwife who KNOWS her formulary confidently and uses it correctly — giving oxytocin within one minute of every birth, vaccinating every pregnant woman against tetanus, ensuring every newborn gets Vitamin K and eye prophylaxis, loading MgSO4 before rushing an eclamptic woman to the hospital — is practicing at the highest standard of her profession and is actively saving lives at the community level. Study the DOSES as exact numbers, know the CONTRAINDICATIONS by heart, understand the TIMING of each drug, be clear on WHAT COMES NEXT after each intervention, and always hold in your mind the boundary between what is YOURS to do and what must be REFERRED. This is the knowledge and the judgment that defines a competent, safe, and effective Filipino registered midwife. Magsipag, magtiyaga, at maging handa — you can do this!

Next chapter

Mandated Newborn Procedures by the Midwife

Ready to practise for the Midwife Licensure Exam 2026?

Super Tutor's AI review plan adapts to your weak areas and builds a weekly practice schedule around your target Midwife Licensure Exam exam date.

Start free See the full Midwife Licensure Exam guide Midwife Licensure Exam preparation guide

← Back to Midwifery Pharmacology & Newborn Procedures hub